Wei Cong Seah will invest globally in early and growth-stage startups in technologies aligned with Genting Group’s diverse business lines.
Wei Cong Seah has left his role as investment manager at Arkray Ventures, the corporate VC arm of Japanese medical device company Arkray, to take on the role of AVP investment at Genting Ventures, the investment arm of conglomerate Genting, which runs resorts, casinos and retail outlets.
A GCV Emerging Leader in 2025, Seah was the first investor hired by Arkray in 2022 to start and build its $87m CVC unit and invest in healthcare and food tech startups globally. In his role, Seah was responsible for investments in southeast and east Asia.
At Genting Ventures, Seah will invest in early and growth-stage startups in the US, southeast Asia and Asia-Pacific in sectors such as AI, gaming and entertainment, hospitality, retail, agritech and food tech, fintech, Web3, biotech and energy.
“I will be expanding our global investments and working closely with founders and our businesses in these verticals,” said Seah, in a LinkedIn post announcing his move.
